Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (601-610 of 715) with videos related to

Pageof 72
Sort By:
Gene Therapy|July 23, 2004
The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transferJ Lievens, J Snoeys, K Vekemans, et al.
Circulation|May 7, 1998
Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in ratsS Janssens, D Flaherty, Z Nong, et al.
The Journal of Experimental Medicine|March 3, 1997
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritisA R Kitching, S R Holdsworth, V A Ploplis, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1994
Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogsR G Kiss, H R Lu, T Roskams, et al.
Scandinavian Journal of Haematology|January 1, 1978
Sensitivity and precision of activated partial thromboplastin time (APTT) methods. A multicenter studyN Refsum, D Collen, H C Godal, et al.
Journal of the American College of Cardiology|May 1, 1989
A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysisT Yasuda, H K Gold, J T Fallon, et al.
FEBS Letters|November 2, 1999
1,25-Dihydroxyvitamin D(3) induction of the tissue-type plasminogen activator gene is mediated through its multihormone-responsive enhancerP Merchiers, F Bulens, I Stockmans, et al.
Circulation|November 1, 1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study GroupD C Stump, R M Califf, E J Topol, et al.
Thrombosis and Haemostasis|May 11, 1999
Structural and functional basis of plasminogen activation by staphylokinaseL Jespers, S Vanwetswinkel, H R Lijnen, et al.
Thrombosis and Haemostasis|August 3, 1992
Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinaseM Dewerchin, A M Vandamme, P Holvoet, et al.
Pageof 72

Showing results (601-610 of 715) with videos related to

Sort By:
Pageof 72
Gene Therapy|July 23, 2004
The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transferJ Lievens, J Snoeys, K Vekemans, et al.
Circulation|May 7, 1998
Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in ratsS Janssens, D Flaherty, Z Nong, et al.
The Journal of Experimental Medicine|March 3, 1997
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritisA R Kitching, S R Holdsworth, V A Ploplis, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1994
Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogsR G Kiss, H R Lu, T Roskams, et al.
Scandinavian Journal of Haematology|January 1, 1978
Sensitivity and precision of activated partial thromboplastin time (APTT) methods. A multicenter studyN Refsum, D Collen, H C Godal, et al.
Journal of the American College of Cardiology|May 1, 1989
A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysisT Yasuda, H K Gold, J T Fallon, et al.
FEBS Letters|November 2, 1999
1,25-Dihydroxyvitamin D(3) induction of the tissue-type plasminogen activator gene is mediated through its multihormone-responsive enhancerP Merchiers, F Bulens, I Stockmans, et al.
Circulation|November 1, 1989
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study GroupD C Stump, R M Califf, E J Topol, et al.
Thrombosis and Haemostasis|May 11, 1999
Structural and functional basis of plasminogen activation by staphylokinaseL Jespers, S Vanwetswinkel, H R Lijnen, et al.
Thrombosis and Haemostasis|August 3, 1992
Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinaseM Dewerchin, A M Vandamme, P Holvoet, et al.
Pageof 72